An update on repurposed medications for the treatment of drug-resistant tuberculosis

File Type .pdf | File Size 972.71 KB

Drug-resistant forms of tuberculosis are a major public health problem with a serious global impact. Although there have recently been two new drugs introduced for the treatment of drug-resistant TB (bedaquiline and delamanid), the current therapeutic armamentarium is limited. Because treatment of drug-resistant TB requires the use of a multi-drug regimen, there has been growing interest in the use of antibiotics developed for other infectious pathogens but that have shown efficacy in the treatment of TB.

Publication Date 
February 2016
Authors 
Arnold Mafukidze, Elizabeth Harausz & Jennifer Furin
Resource Type 
Publications
Peer-reviewed Journal Articles
Regions/ Countries 
Language 
English